University of California gains ground after EPO backs CRISPR patent
11-02-2020
EPO appeals board weighs-up Broad’s CRISPR claims
14-01-2020
Broad Institute to appeal CRISPR patent revocation
17-01-2018
Servickuz / Shutterstock.com
The Board of Appeal of the European Patent Office (EPO) has issued new communication summarising issues that will be discussed at a hearing on whether the EPO erred in its revocation of a patent owned by the Broad Institute.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
CRISPR/Cas9, Broad Institute, Massachusetts Institute of Technology, European Patent Office, Board of Appeal
